Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Cash from Financing Activities (2020 - 2025)

Trulieve Cannabis has reported Cash from Financing Activities over the past 6 years, most recently at -$255.4 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$255.4 million for Q4 2025, down 3917.49% from a year ago — trailing twelve months through Dec 2025 was -$270.5 million (down 708.93% YoY), and the annual figure for FY2025 was -$270.5 million, down 708.93%.
  • Cash from Financing Activities for Q4 2025 was -$255.4 million at Trulieve Cannabis, down from -$4.8 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TCNNF hit a ceiling of $220.5 million in Q2 2021 and a floor of -$255.4 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was -$4.0 million (2023), compared with a mean of -$624650.0.
  • Biggest five-year swings in Cash from Financing Activities: surged 1434.31% in 2021 and later tumbled 3917.49% in 2025.
  • Trulieve Cannabis' Cash from Financing Activities stood at $59.8 million in 2021, then surged by 43.54% to $85.9 million in 2022, then tumbled by 233.94% to -$115.0 million in 2023, then surged by 94.47% to -$6.4 million in 2024, then tumbled by 3917.49% to -$255.4 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$255.4 million (Q4 2025), -$4.8 million (Q3 2025), and -$5.8 million (Q2 2025) per Business Quant data.